{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:25:25Z","timestamp":1793921125897,"version":"4.8.0"},"reference-count":7,"publisher":"Innovative Healthcare Institute","issue":"4","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,13]]},"DOI":"10.36401\/jipo-26-x7","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:20:26Z","timestamp":1791865226000},"page":"252-253","source":"Crossref","is-referenced-by-count":0,"title":["Evidence for Dose Optimization of Immune Checkpoint Inhibitors"],"prefix":"10.36401","volume":"9","author":[{"given":"Sewanti","family":"Limaye","sequence":"first","affiliation":[{"name":"Division of Medical and Precision Oncology, Sir HN Reliance Foundation Hospital and Research Center, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanita","family":"Noronha","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Prabhash","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22027","reference":[{"key":"i2590-017X-9-4-252-b01","series-title":"J Immunother Precis Oncol","first-page":"153","article-title":"Immune checkpoint inhibitors journey: from promise to lasting impact","volume":"9","author":"Hajjar","year":"2026","unstructured":"Hajjar J,Stephen B,Aaroe A, et al. Immune checkpoint inhibitors journey: from promise to lasting impact. J Immunother Precis Oncol. 2026;9:153\u2013245. DOI: 10.36401\/JIPO-26-12"},{"key":"i2590-017X-9-4-252-b02","series-title":"Nat Rev Cancer","first-page":"275","article-title":"Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy","volume":"16","author":"Topalian","year":"2016","unstructured":"Topalian SL,Taube JM,Anders RA,Pardoll DM. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat Rev Cancer. 2016;16:275\u2013287. DOI: 10.1038\/nrc.2016.36"},{"key":"i2590-017X-9-4-252-b03","series-title":"CPT Pharmacometrics Syst Pharmacol","first-page":"58","article-title":"Model-based population pharmacokinetic analysis of nivolumab in patients with solid tumors","volume":"6","author":"Bajaj","year":"2017","unstructured":"Bajaj G,Wang X,Agrawal S, et al. Model-based population pharmacokinetic analysis of nivolumab in patients with solid tumors. CPT Pharmacometrics Syst Pharmacol. 2017;6:58\u201366. DOI: 10.1002\/psp4.12143"},{"key":"i2590-017X-9-4-252-b04","series-title":"J Clin Oncol","first-page":"1083","article-title":"Efficacy and safety of ultra-low-dose immunotherapy in relapsed refractory solid tumors: phase III superiority randomized trial (DELII)","volume":"44","author":"Noronha","year":"2026","unstructured":"Noronha V,Patil V,Menon N, et al. Efficacy and safety of ultra-low-dose immunotherapy in relapsed refractory solid tumors: phase III superiority randomized trial (DELII). J Clin Oncol. 2026;44:1083\u20131097. DOI: 10.1200\/JCO-25-01546"},{"key":"i2590-017X-9-4-252-b05","series-title":"Cancer Chemother Pharmacol","first-page":"659","article-title":"Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer","volume":"94","author":"Gandhi","year":"2024","unstructured":"Gandhi KA,Shirsat A,Hj SK, et al. Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer. Cancer Chemother Pharmacol. 2024;94:659\u2013668. DOI: 10.1007\/s00280-024-04697-x"},{"key":"i2590-017X-9-4-252-b06","series-title":"J Clin Oncol","first-page":"222","article-title":"Low-dose immunotherapy in head and neck cancer: a randomized study","volume":"41","author":"Patil","year":"2023","unstructured":"Patil VM,Noronha V,Menon N, et al. Low-dose immunotherapy in head and neck cancer: a randomized study. J Clin Oncol. 2023;41:222\u2013232. DOI: 10.1200\/JCO.22.01015"},{"key":"i2590-017X-9-4-252-b07","series-title":"South Asian J Cancer","first-page":"70","article-title":"Efficacy and safety of low-dose nivolumab in treatment of advanced solid tumors: a retrospective audit from resource-constrained settings","volume":"14","author":"Kumar","year":"2025","unstructured":"Kumar A,Kapoor A,Noronha V, et al. Efficacy and safety of low-dose nivolumab in treatment of advanced solid tumors: a retrospective audit from resource-constrained settings. South Asian J Cancer. 2025;14:70\u201376. DOI: 10.1055\/s-0044-1788649"}],"container-title":["Journal of Immunotherapy and Precision Oncology"],"original-title":[],"link":[{"URL":"https:\/\/innovationsjournals-jipo.kglmeridian.com\/view\/journals\/jipo\/9\/4\/article-p252.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/innovationsjournals-jipo.kglmeridian.com\/downloadpdf\/journals\/jipo\/9\/4\/article-p252.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/innovationsjournals-jipo.kglmeridian.com\/downloadpdf\/journals\/jipo\/9\/4\/article-p252.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:35:31Z","timestamp":1793918131000},"score":1,"resource":{"primary":{"URL":"https:\/\/innovationsjournals-jipo.kglmeridian.com\/view\/journals\/jipo\/9\/4\/article-p252.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":7,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.36401\/jipo-26-x7","relation":{},"ISSN":["2590-017X","2666-2345"],"issn-type":[{"value":"2590-017X","type":"electronic"},{"value":"2666-2345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,13]]}}}